Regenxbio (RGNX) Debt to Equity (2014)
Regenxbio (RGNX) recorded quarterly Debt to Equity of -$0.08 in Q4 2014.
Regenxbio (RGNX) Debt to Equity (2014) Analysis & Trends
Regenxbio's Debt to Equity history runs 1 years deep, the most recent figure standing at -$0.08 for Q4 2014.
- In Q4 2014, Debt to Equity changed N/A year-over-year to -$0.08; the TTM figure through Dec 2014 stood at -$0.08 (changed N/A YoY), while the FY2014 annual figure was -$0.08, changed N/A from the prior year.
- Debt to Equity was -$0.08 for Q4 2014 at Regenxbio.
- In the past five years, Debt to Equity ranged from a high of -$0.08 in Q4 2014 to a low of -$0.08 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Regenxbio | 315.11 Mn | 85.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -0.08 |